ROIV
Roivant Sciences Ltd.
Stock
$35.72+0.22 (+0.62%)Close Oct 2, 2026
- Stock-based compensation, FY2025
- $346M
- YoY, FY2025
- +19.8%
- 5-year CAGR
- +32.4%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| FY2025 | $346M | +19.8% |
| FY2024 | $289M | +44.8% |
| FY2023 | $200M | −8.3% |
| FY2022 | $218M | −61.5% |
| FY2021 | $565M | +565.0% |
| FY2020 | $85M | — |